gartisertib

Term ID

CHEBI:231616

Synonyms

2-amino-6-fluoro-N-(5-fluoro-4-(4-(4-(oxetan-3-yl)piperazine-1-carbonyl)piperidin-1-yl)pyridin-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
2-amino-6-fluoro-N-[5-fluoro-4-(4-{[4-(oxetan-3-yl)piperazin-1-yl]carbonyl}piperidin-1-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
gartisertib
gartisertibum
M 4344
M-4344
M4344
VX-803

Definition

A member of the class of pyrazolopyrimidines that is pyrazolo[1,5-a]pyrimidine substituted by amino, N-[5-fluoro-4-(4-{[4-(oxetan-3-yl)piperazin-1-yl]carbonyl}piperidin-1-yl)pyridin-3-yl]aminoacyl, and fluoro groups at positions 2, 3 and 6, respectively. It is an inhibitor of ataxia telangiectasia and Rad3 related (ATR) kinase that exhibits antineoplastic activity.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: aromatic amine N-acylpiperazine organofluorine compound oxetanes piperidinecarboxamide ... Show All 9 Terms

aromatic amine N-acylpiperazine organofluorine compound oxetanes piperidinecarboxamide primary amino compound pyrazolopyrimidine pyridines secondary carboxamide Show first 5 Terms
has_role: antineoplastic agent EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor

antineoplastic agent EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor Show first 5 Terms

Phenotype

Phenotype resulting from gartisertib

Phenotype where environments contain gartisertib

Phenotype modified by environments containing gartisertib

Human Disease Model